Anti-Viral Therapies Market Trends, Size, Segments, Emerging Technologies 2027
Technology

Anti-Viral Therapies Market Trends, Size, Segments, Emerging Technologies 2027

Anti-Viral Therapies Market

marketreportsnews
marketreportsnews
4 min read

Market Overview:

According to our new market research study on “Anti-Viral Therapies Market to 2027 - Global Analysis and Forecast - by Type, Mechanism of Action, and End User,” the market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the global anti - viral therapies market and the drivers and restraints pertaining to the market growth.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00012650/

Based on type, the global anti - viral therapies market is segmented into generic drugs and branded drugs. The generic drugs segment is estimated to register a higher CAGR in the market during 2020–2027. Rising demand for low-cost drugs, growing number of FDA-approved generic drugs, rising adoption in emerging nations, and patent expiry of various branded products are the factors boosting the market for the generic drugs segment.

The global anti - viral therapies market growth is mainly attributed to factors such as increasing R&D expenditure in pharmaceutical companies and rising government support for research activities and clinical trials. However, high drug development cost hinders the growth of the market.

AbbVie Inc.; Abbott; Astrazeneca; F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Gilead Sciences, Inc.; GlaxoSmithKline plc; and Aurobindo Pharma are among the leading companies operating in the anti - viral therapies market.

Buy Now:  https://www.theinsightpartners.com/buy/TIPRE00012650/

The Report Segments Global Anti - Viral Therapies Market as Follows:

By Type

Generic DrugsBranded Drugs

By Mechanism of Action

Nucleotide Polymerase InhibitorsReverse Transcriptase InhibitorsProtease InhibitorsOthers

By Application

HIVHepatitisHerpesVirus InfluenzaOther Applications

By Geography

North AmericaUSCanadaMexicoEuropeFranceGermanyUKSpainItalyAsia Pacific (APAC)ChinaIndiaJapanAustraliaSouth KoreaMiddle East and Africa (MEA)Saudi ArabiaUAESouth AfricaSouth and Central America (SCAM)BrazilArgentina

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected]  

Phone: +1-646-491-9876

 

 

0

Discussion (0 comments)

0 comments

No comments yet. Be the first!